The global high-flow oxygen therapy devices market is projected to experience steady growth, with revenue expected to rise from USD 1,494.8 million in 2023 to USD 1,567.2 million by 2033, reflecting a compound annual growth rate (CAGR) of 0.5% over the forecast period. This growth is primarily driven by the increasing incidence of acute respiratory failure and the growing need for non-invasive respiratory support in patients worldwide.
Key Market Drivers
The rise in respiratory conditions, especially among patients with acute respiratory failure, has intensified the demand for high-flow oxygen therapy devices. These devices are essential for providing critical respiratory support to patients in hospitals and at home, offering a non-invasive alternative to traditional mechanical ventilation.
Growing Demand for Heated Humidifiers
The demand for heated humidifiers is projected to be a major contributor to market growth. These devices play a crucial role in improving patient comfort and preventing airway drying during oxygen therapy. Heated humidifiers are expected to account for more than 48.18% of total high-flow oxygen therapy device sales in 2023, underlining their importance in the overall therapy process.
Market Outlook
As healthcare systems worldwide continue to address the rising burden of respiratory diseases, the high-flow oxygen therapy devices market is set to witness steady sales growth. Advances in device technologies and the increasing focus on non-invasive therapies are expected to drive the demand for these solutions throughout the forecast period.
Key Takeaways:
The high-flow oxygen therapy devices market is projected to reach USD 1,567.2 million by 2033, growing at a 0.5% CAGR.
The rising incidence of acute respiratory failure and the need for non-invasive respiratory support are driving market demand.
Heated humidifiers are expected to account for more than 48.18% of the market share in 2023.
Advances in therapy technologies and increasing healthcare needs support steady market growth.
Key Growth Drivers
Increasing Incidence of Acute Respiratory Failure:
The rising number of patients experiencing acute respiratory failure, particularly due to infections, is driving demand for high-flow oxygen therapy devices. These devices provide essential non-invasive respiratory support.
Demand for Heated Humidifiers:
Heated humidifiers are expected to account for over 48.18% of high-flow oxygen therapy device sales in 2023, reflecting their importance in enhancing patient comfort and treatment effectiveness.
Growing Health Concerns:
An increase in health concerns related to respiratory diseases is prompting healthcare providers to adopt high-flow oxygen therapy solutions more widely.
Technological Advancements:
Continuous improvements in the design and functionality of high-flow oxygen therapy devices are making them more user-friendly and effective, thereby increasing their adoption in clinical settings.
Rising Healthcare Expenditure:
Increased healthcare spending globally is facilitating the purchase and implementation of advanced medical technologies, including high-flow oxygen therapy devices.
Emergence of Home Healthcare Solutions:
The growing trend towards home healthcare is driving demand for portable and easy-to-use high-flow oxygen therapy devices that can be utilized outside traditional hospital settings.
Market Dynamics
The market is characterized by a variety of product offerings, including different types of delivery systems and accessories that enhance the effectiveness of high-flow oxygen therapy.
The demand for these devices is expected to remain stable despite the relatively low CAGR, as they play a critical role in managing respiratory conditions effectively.
Key Players in the Market
Draegerwerk AG & Co. KGaA
Teleflex Medical GmBH
Philips Respironics
Vapotherm, Inc.
ResMed
Vyaire Medical, Inc.
Fisher & Paykel Corporation Ltd.
Armstrong Medical
Flexicare Medical
Hamilton Medical Inc.
Intersurgical Inc.
Inspired Medical
WILAMed GmBH
Besmed Health Business Corp
Shenzhen Micomme Medical Technology Development Co. Ltd
Shenyang RMS Medical Tech Co. Ltd.
BMC Medical Co., Ltd.
High-flow Oxygen Therapy Devices Market by Category
Product:
High-flow Nasal Cannulas
High-flow Oxygen Masks
Breathing Circuits
Heated Humidifiers
Accessories
Application:
Pneumonia
Acute Respiratory Failure
End User:
Less than 100 Beds in Hospitals
100 to 250 Beds Hospitals
250 to 500 Beds Hospitals
500 Beds and Above Hospitals
Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA T: +1-347-918-3531